Ignite Creation Date:
2025-12-24 @ 3:15 PM
Ignite Modification Date:
2026-01-22 @ 7:13 AM
Study NCT ID:
NCT04976192
Status:
COMPLETED
Last Update Posted:
2025-10-07
First Post:
2021-07-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Compare Efficacy and Safety of TEV-45779 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria
Sponsor:
Teva Pharmaceuticals USA
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Chronic Urticaria | View |
Keywords: